U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775404) titled 'A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus' on Aug. 17.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exercise for weight management, in adult participants living with obesity or overweight with or without T2DM.
Study Start Date: Aug. 28
Study Type: INTERVENTIONAL
Condition:
Obesity
Overweight
Intervention:
DRUG: Elecoglipron
Elecoglipron film coated tablet once daily
DRUG: Placebo
Placebo matching elecoglipron film-coated ta...